Illumina Spin-off to Develop Early-Detection Test.
作者:
Colwell(Janet)
状态:
发布时间2016-04-05
, 更新时间 2016-04-05
期刊:
Cancer Discov
摘要:
DNA-sequencing giant Illumina has formed a new company, called Grail, to develop liquid biopsies capable of spotting cancer before symptoms arise. The start-up is working on a low-cost "pan-cancer" test that can detect multiple cancer types early, which it hopes to introduce by 2019.